相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Randomised clinical trials in critical care: past, present and future
Anders Granholm et al.
INTENSIVE CARE MEDICINE (2022)
Model-informed precision dosing of beta-lactam antibiotics and ciprofloxacin in critically ill patients: a multicentre randomised clinical trial
Tim M. J. Ewoldt et al.
INTENSIVE CARE MEDICINE (2022)
Hospital-onset sepsis and community-onset sepsis in critical care units in Japan: a retrospective cohort study based on a Japanese administrative claims database
Mayuko Tonai et al.
CRITICAL CARE (2022)
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Laura Evans et al.
INTENSIVE CARE MEDICINE (2021)
Continuous infusion versus intermittent administration of meropenem in critically ill patients (MERCY): A multicenter randomized double-blind trial. Rationale and design
Giacomo Monti et al.
CONTEMPORARY CLINICAL TRIALS (2021)
Comparative in vitro antimicrobial potency, stability, colouration and dissolution time of generics versus innovator of meropenem in Europe
Isabelle K. Delattre et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#
Mohd H. Abdul-Aziz et al.
INTENSIVE CARE MEDICINE (2020)
Clinical outcomes of continuous vs intermittent meropenem infusion for the treatment of sepsis: A systematic review and meta-analysis
Peng Chen et al.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2020)
Prolonged versus intermittent β-lactam antibiotics intravenous infusion strategy in sepsis or septic shock patients: a systematic review with meta-analysis and trial sequential analysis of randomized trials
Yutaka Kondo et al.
JOURNAL OF INTENSIVE CARE (2020)
Extended vs Bolus Infusion of Broad-Spectrum β-Lactams for Febrile Neutropenia: An Unblinded, Randomized Trial
Ron Ram et al.
CLINICAL INFECTIOUS DISEASES (2018)
Extended infusion-putting the benefit into context
Markus Zeitlinger
LANCET INFECTIOUS DISEASES (2018)
beta-lactam prolonged infusion: it's time to implement!
Mical Paul et al.
LANCET INFECTIOUS DISEASES (2018)
Prolonged versus short-term intravenous infusion of antipseudomonal beta-lactams for patients with sepsis: a systematic review and meta-analysis of randomised trials
Konstantinos Z. Vardakas et al.
LANCET INFECTIOUS DISEASES (2018)
Clinical outcomes of prolonged infusion (extended infusion or continuous infusion) versus intermittent bolus of meropenem in severe infection: A meta-analysis
Zhenwei Yu et al.
PLOS ONE (2018)
Appropriate endpoints for evaluation of new antibiotic therapies for severe infections: a perspective from COMBACTE's STAT-Net
Jean-Francois Timsit et al.
INTENSIVE CARE MEDICINE (2017)
Pharmacokinetic and Pharmacodynamic Efficacies of Continuous versus Intermittent Administration of Meropenem in Patients with Severe Sepsis and Septic Shock: A Prospective Randomized Pilot Study
Hui-Ying Zhao et al.
CHINESE MEDICAL JOURNAL (2017)
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
Andrew Rhodes et al.
CRITICAL CARE MEDICINE (2017)
Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis A Meta-analysis of Individual Patient Data from Randomized Trials
Jason A. Roberts et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
The ANTIBIOPERF study: a nationwide cross-sectional survey about practices for β-lactam administration and therapeutic drug monitoring among critically ill patients in France
A. Charmillon et al.
CLINICAL MICROBIOLOGY AND INFECTION (2016)
The negative impact of antibiotic resistance
N. D. Friedman et al.
CLINICAL MICROBIOLOGY AND INFECTION (2016)
Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis
Mohd H. Abdul-Aziz et al.
INTENSIVE CARE MEDICINE (2016)
Should β-lactam antibiotics be administered by continuous infusion in critically ill patients? A survey of Australia and New Zealand intensive care unit doctors and pharmacists
Menino O. Cotta et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
Mervyn Singer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
β-Lactams and β-Lactamase Inhibitors: An Overview
Karen Bush et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
A Multicenter Randomized Trial of Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis
Joel M. Dulhunty et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Prolonged infusion versus intermittent boluses of β-lactam antibiotics for treatment of acute infections: a meta-analysis
Jocelyn Teo et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
A tutorial on sensitivity analyses in clinical trials: the what, why, when and how
Lehana Thabane et al.
BMC MEDICAL RESEARCH METHODOLOGY (2013)
Clinical Outcomes With Extended or Continuous Versus Short-term Intravenous Infusion of Carbapenems and Piperacillin/Tazobactam: A Systematic Review and Meta-analysis
Matthew E. Falagas et al.
CLINICAL INFECTIOUS DISEASES (2013)
Continuous Infusion of Beta-Lactam Antibiotics in Severe Sepsis: A Multicenter Double-Blind, Randomized Controlled Trial
Joel M. Dulhunty et al.
CLINICAL INFECTIOUS DISEASES (2013)
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
A. -P. Magiorakos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
What's behind the failure of emerging antibiotics in the critically ill? Understanding the impact of altered pharmacokinetics and augmented renal clearance
Andrew A. Udy et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Drotrecogin Alfa (Activated) in Adults with Septic Shock
V. Marco Ranieri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Carbapenem antibiotics for serious infections
Peter M. Hawkey et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
Clinical and microbiological efficacy of continuous versus intermittent application of meropenem in critically ill patients: a randomized open-label controlled trial
Ivan Chytra et al.
CRITICAL CARE (2012)
Early use of imipenem/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobials without de-escalation for patients with hospital-acquired pneumonia in a medical ICU: a randomized clinical trial
Jong Wook Kim et al.
CRITICAL CARE (2012)
Antimicrobial utilisation in 37 Australian and New Zealand intensive care units
J. M. Dulhunty et al.
ANAESTHESIA AND INTENSIVE CARE (2011)
Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution
Jason A. Roberts et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Continuous infusion of β-lactam antibiotics in severe infections:: a review of its role
Jason A. Roberts et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults
Lionel A. Mandell et al.
CLINICAL INFECTIOUS DISEASES (2007)
Application of antimicrobial pharmacodynamic concepts into clinical practice: Focus on beta-lactam antibiotics - Insights from the society of infectious diseases pharmacists
Thomas P. Lodise et al.
PHARMACOTHERAPY (2006)
Guidelines for the management, of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia
[Anonymous]
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Continuous versus intermittent intravenous administration of antibacterials with time-dependent action - A systematic review of pharmacokinetic and pharmacodynamic parameters
SK Kasiakou et al.
DRUGS (2005)
Antimicrobial pharmacodynamics: Critical interactions of 'bug and drug'
GL Drusano
NATURE REVIEWS MICROBIOLOGY (2004)
Composite outcomes in randomized trials - Greater precision but with greater uncertainty?
N Freemantle et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
MM Levy et al.
CRITICAL CARE MEDICINE (2003)
Meropenem - A review of its use in patients in intensive care
M Hurst et al.
DRUGS (2000)
分享论文
